Youzhi Zhu

Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Correction: SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer.

Correction: SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer.

Journal: Frontiers in oncology

Published: April 16, 2026

[68Ga]Ga-labeled fibroblast activation protein inhibitor PET/CT for monitoring neoadjuvant chemotherapy responses in breast cancer subtypes.

[68Ga]Ga-labeled fibroblast activation protein inhibitor PET/CT for monitoring neoadjuvant chemotherapy responses in breast cancer subtypes.

Journal: Breast cancer research : BCR

Published: October 22, 2025

The value of serial [⁶⁸Ga]Ga-FAPI-04 PET/CT in predicting pathological response and evaluating therapeutic efficacy to neoadjuvant chemotherapy in breast cancer.

The value of serial [⁶⁸Ga]Ga-FAPI-04 PET/CT in predicting pathological response and evaluating therapeutic efficacy to neoadjuvant chemotherapy in breast cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 08, 2025

Elemental comparative analysis of 18 elements reveal distinct patterns in benign and malignant thyroid tissues.

Elemental comparative analysis of 18 elements reveal distinct patterns in benign and malignant thyroid tissues.

Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

Published: January 12, 2025

NR4A1 suppresses breast cancer growth by repressing c-Fos-mediated lipid and redox dyshomeostasis.

NR4A1 suppresses breast cancer growth by repressing c-Fos-mediated lipid and redox dyshomeostasis.

Journal: Experimental & molecular medicine

Published: April 23, 2024

Homogentisic acid metabolism inhibits papillary thyroid carcinoma proliferation through ROS and p21-induced cell cycle arrest.

Homogentisic acid metabolism inhibits papillary thyroid carcinoma proliferation through ROS and p21-induced cell cycle arrest.

Journal: Life sciences

Published: February 28, 2024

Construction of a risk model based on N6 -methyladenosinerelated lncRNAs for predicting the prognosis of breast cancer.

Construction of a risk model based on N6 -methyladenosinerelated lncRNAs for predicting the prognosis of breast cancer.

Journal: Journal of biosciences

Published: August 04, 2023

68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study.

68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: May 26, 2023

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.

Journal: Cell death & disease

Published: April 03, 2023

68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study.

68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study.

Journal: Clinical nuclear medicine

Published: February 01, 2023

Optical biosensor based on SERS with signal calibration function for quantitative detection of carcinoembryonic antigen.

Optical biosensor based on SERS with signal calibration function for quantitative detection of carcinoembryonic antigen.

Journal: Biomedical optics express

Published: August 29, 2022

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer.

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer.

Journal: Frontiers in oncology

Published: June 19, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026